FASN and prostate carcinoma: Moreover, uptake of radiolabeled acetate can reflect FASN expression levels and further the sensitivity to FASN-targeted therapy in prostate cancer cell lines as it reduces significantly with the presence of FASN inhibitors (131, 183).